pI: 4.1305 |
Length (AA): 119 |
MW (Da): 12931 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 114 | 1i7h (A) | 2 | 110 | 40.00 | 0 | 1 | 1.38 | -0.7 |
3 | 105 | 2bt6 (A) | 8 | 108 | 46.00 | 0 | 1 | 1.39 | -1.33 |
3 | 105 | 2bt6 (A) | 8 | 108 | 49.00 | 0 | 1 | 1.5 | -0.98 |
3 | 105 | 2bt6 (A) | 8 | 108 | 49.00 | 0 | 1 | 1.52 | -1.18 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_126994)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G21090 | ferredoxin 2 |
Arabidopsis thaliana | AT4G05450 | mitochondrial ferredoxin 1 |
Babesia bovis | BBOV_IV001460 | adrenodoxin-type ferredoxin, putative |
Brugia malayi | Bm1_55765 | 2Fe-2S iron-sulfur cluster binding domain containing protein |
Brugia malayi | Bm1_36585 | Adrenodoxin-like protein, mitochondrial precursor, putative |
Candida albicans | CaO19.336 | oxidoreductase |
Candida albicans | CaO19.7969 | oxidoreductase |
Caenorhabditis elegans | CELE_Y73F8A.27 | Protein Y73F8A.27 |
Cryptosporidium parvum | cgd6_3000 | ferredoxin-like protein Fd1, putative |
Dictyostelium discoideum | DDB_G0267486 | hypothetical protein |
Drosophila melanogaster | Dmel_CG4205 | Ferredoxin |
Drosophila melanogaster | Dmel_CG1319 | CG1319 gene product from transcript CG1319-RB |
Escherichia coli | b2525 | [2Fe-2S] ferredoxin |
Echinococcus granulosus | EgrG_000190000 | ferredoxin |
Echinococcus granulosus | EgrG_000040700 | Adrenodoxin mitochondrial |
Echinococcus multilocularis | EmuJ_000190000 | ferredoxin adrenodoxin |
Echinococcus multilocularis | EmuJ_000040700 | Adrenodoxin, mitochondrial |
Giardia lamblia | GL50803_27266 | [2Fe-2S] ferredoxin |
Homo sapiens | ENSG00000267673 | ferredoxin 1-like |
Homo sapiens | ENSG00000137714 | ferredoxin 1 |
Leishmania braziliensis | LbrM.31.2770 | ferredoxin 2fe-2s-like protein |
Leishmania braziliensis | LbrM.26.1070 | hypothetical protein, conserved |
Leishmania braziliensis | LbrM.31.2820 | ferredoxin 2fe-2s-like protein |
Leishmania donovani | LdBPK_312570.1 | ferredoxin 2fe-2s-like protein |
Leishmania donovani | LdBPK_261030.1 | 2Fe-2S iron-sulfur cluster binding domain containing protein, putative |
Leishmania infantum | LinJ.31.2570 | ferredoxin 2fe-2s-like protein |
Leishmania infantum | LinJ.26.1030 | hypothetical protein, conserved |
Leishmania major | LmjF.31.2480 | ferredoxin 2fe-2s-like protein |
Leishmania major | LmjF.26.1050 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.30.2480 | ferredoxin 2fe-2s-like protein |
Leishmania mexicana | LmxM.26.1050 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_00128 | 2Fe-2S iron-sulfur cluster binding domain-containing protein |
Mus musculus | ENSMUSG00000079677 | ferredoxin 1-like |
Mus musculus | ENSMUSG00000032051 | ferredoxin 1 |
Neospora caninum | NCLIV_016870 | hypothetical protein |
Neospora caninum | NCLIV_050330 | 2Fe-2S iron-sulfur cluster binding domain containing protein, putative |
Oryza sativa | 4342226 | Os07g0110300 |
Oryza sativa | 4347157 | Os09g0437900 |
Onchocerca volvulus | OVOC4595 |
|
Onchocerca volvulus | OVOC705 | Adrenodoxin, mitochondrial homolog |
Plasmodium berghei | PBANKA_1430400 | adrenodoxin-type ferredoxin, putative |
Plasmodium falciparum | PF3D7_1214600 | adrenodoxin-type ferredoxin, putative |
Plasmodium knowlesi | PKNH_1434100 | adrenodoxin-type ferredoxin, putative |
Plasmodium yoelii | PY07468 | Adrenodoxin precursor |
Saccharomyces cerevisiae | YPL252C | Yah1p |
Schistosoma japonicum | Sjp_0037340 | ko:K04755 ferredoxin, 2Fe-2S, putative |
Schistosoma japonicum | Sjp_0028320 | Adrenodoxin, mitochondrial precursor, putative |
Schistosoma mansoni | Smp_124940 | adrenodoxin |
Schistosoma mansoni | Smp_016910 | adrenodoxin |
Schmidtea mediterranea | mk4.039500.00 | |
Schmidtea mediterranea | mk4.000884.02 | |
Trypanosoma brucei gambiense | Tbg972.7.840 | electron transfer protein, putative |
Trypanosoma brucei | Tb927.4.4980 | NADH-ubiquinone oxidoreductase complex I subunit, putative |
Trypanosoma brucei | Tb927.7.890 | electron transfer protein, putative |
Trypanosoma congolense | TcIL3000_7_480 | electron transfer protein, putative |
Trypanosoma congolense | TcIL3000_0_52800 | electron transfer protein, putative |
Trypanosoma congolense | TcIL3000_8_7670 | adrenodoxin precursor, putative |
Trypanosoma congolense | TcIL3000_4_4210 | adrenodoxin precursor, putative |
Trypanosoma cruzi | TcCLB.508879.70 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.504575.40 | adrenodoxin precursor, putative |
Trypanosoma cruzi | TcCLB.421057.10 | adrenodoxin precursor, putative |
Trypanosoma cruzi | TcCLB.509011.70 | adrenodoxin precursor, putative |
Toxoplasma gondii | TGME49_236000 | ferredoxin, putative |
Toxoplasma gondii | TGME49_240670 | adrenodoxin-type ferredoxin, putative |
Theileria parva | TP01_0173 | adrenodoxin-type ferredoxin, putative |
Trichomonas vaginalis | TVAG_078730 | Ferredoxin 7 |
Wolbachia endosymbiont of Brugia malayi | Wbm0507 | ferredoxin |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.7.890 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.890 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.890 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.7.890 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.4.4980 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.4.4980 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.4.4980 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.4.4980 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y73F8A.27 | Caenorhabditis elegans | embryonic arrest | wormbase |
YPL252C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1430400 | Plasmodium berghei | Essential | plasmo |
TGME49_240670 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_236000 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_240670 | Toxoplasma gondii | Probably essential | sidik |
TGME49_236000 | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.